AbbVie Inc (ABBV) earnings · P/E 81, rev $61.16B
These earnings events as JSON? API free 100/dayAbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
This ABBV earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.7.
When the next ABBV 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 8.6% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full ABBV research stays on the stock page; the tape stays on the quote page.
ABBV earnings FAQ
What are ABBV's latest revenue and net income?
Latest cached AbbVie Inc (ABBV) revenue for Dec 31, 2025 was $61.16B. Net income was $4.23B. Statements: https://lician.com/financials/abbv
What is ABBV's latest diluted EPS?
Latest cached AbbVie Inc (ABBV) diluted EPS for Dec 31, 2025 was $2.36.
What period does the latest ABBV earnings print cover?
The latest cached AbbVie Inc (ABBV) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did ABBV revenue change from the prior cached period?
Cached AbbVie Inc (ABBV) revenue was up 8.6% from $56.33B (Dec 31, 2024) to $61.16B (Dec 31, 2025). Statements: https://lician.com/financials/abbv
What is ABBV's P/E ratio?
AbbVie Inc (ABBV) trailing P/E is 80.7 on the latest cached fundamentals snapshot.
Where are ABBV earnings listed?
Cached earnings facts for AbbVie Inc (ABBV) are listed at https://lician.com/earnings/abbv. Statements: https://lician.com/financials/abbv
Not investment advice.